MENU
SCNI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Scinai Immunotherapeutics (SCNI) Ownership - Who owns Scinai Immunotherapeutics?

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business... Show more

Profile

Industry
Pharmaceuticals Major
Address
Hadassah Ein Kerem Campus
Phone
+972 89302529
Employees
45
Web
https://www.scinai.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
298.81K
P/E Ratio
0.02
Total Cash
2.65M
Projected Growth
0.04
Total Debt
3.58M
Revenue
1.49M
Risk (Beta)
1.95
Dividend Yield
N/A
Total Cash/Share
3.92
Total Debt/Equity
N/A
Revenue/Share
2.80 USD as % of share price
Who owns Scinai Immunotherapeutics? SCNI symbol Ownership - Tickeron.com